Tscan Therapeutics

TCRX

Tscan Therapeutics has been a target of short sellers for a while. The current short interest of 2.76% is roughly at the average of the last 12 months (2.60%).

Short Interest Trend

Share Price

Total NSP

2.76%

+0.24%

vs. last month

Also interesting? All insider buys at Tscan Therapeutics

Found an error? Questions? Ideas?